Nalmefene for reducing alcohol consumption in people with alcohol dependence

  • Technology appraisal guidance
  • TA325
  • Published: 

Review decision – May 2018

Decision to move the existing guidance to the static list

We would like to update you on the decision made regarding the review of the existing guidance on TA325; Nalmefene for reducing alcohol consumption in people with alcohol dependence.

There are no new evidence that warrants an update of the existing recommendations. 

Consequently NICE’s Guidance Executive has decided that TA325 should move to the ‘static list’ of technology appraisals without consultation.

Review decision paper

This page was last updated: